期刊文献+

川崎病患儿血小板膜糖蛋白Ibα基因多态性分析

Investigation of platelet membrane glycoprotein Ibα gene polymorphisms in children with Kawasaki disease
原文传递
导出
摘要 目的研究血小板膜糖蛋白Ibα(GPIbot)基因HPA-2a/b多态性与KD发病及并发冠状动脉损伤(CAL)之间的关系。方法应用聚合酶链反应-限制性内切酶片断长度多态性分析技术结合琼脂糖凝胶电泳技术,检测30例KD患儿和60例健康对照组儿童GPIbα基因HPA-2a/b多态性位点的基因型和等位基因分布。结果本组KD病例和健康对照组儿童GPIbα基因HPA-2a/b的基因型均只有TC型和CC型,而未发现TT型。KD组GPIbα基因HPA-2a/b多态性的CC、TC、TT基因型分布频率和C、T等位基因频率与健康对照组比较差异均无统计学意义(χ2=0.052、0.048,P均〉0.05),KD组中合并CAL组与无CAL组基因型分布频率和等位基因频率比较差异亦无统计学意义(χ2=2.672、2.481,P均〉0.05)。结论GPIba基因的HPA-2a/b多态性与KD及其CAL的发生均无明显相关性。 Objective To investigate the association between platelet glycoprotein Iba (GPIbα) gene HPA- 2a/b polymorphisms and the risk of Kawasaki disease (KD) and that complicated with coronary artery lesion (CAL). Methods A total of 30 patients with KD and 60 healthy controls were genotyped by polymerase chain reaction-restriction fragment length polymorphism and agarose gel electrophoresis for the HPA-2a/b polymorphism in GPIbα gene. Resuits For HPA-2a/b polymorphism in GPIbα gene, there was only genotype TC and CC of HPA-2a/b polymorphism in GPlbol gene in children with KD and healthy controls, and genotype TT was not found in both groups. There were no significant differences between KD patients and the controls in genotype frequencies of CC, TC and TT and allele frequencies of C and T (χ2 = 0. 052,0. 048 ,all P 〉 0.05 ) ; also there was no significant difference between KD patients with CAL and that without CAL in genotype and allele frequencies (χ2 = 2. 672,2. 481, all P 〉 0.05 ). Conclusion No association is found between HPA-2a/b polymorphism in GPIbα gene and the risk of KD or its complication of CAL in this study.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2013年第3期220-222,共3页 Chinese Journal of Applied Clinical Pediatrics
关键词 血小板膜糖蛋白IBΑ 川崎病 基因多态性 Platelet glycoprotein Ibα Kawasaki disease Gene polymorphism
  • 相关文献

参考文献14

  • 1韩冬,杨作成.川崎病治疗的研究进展[J].医学综述,2011,17(9):1367-1369. 被引量:11
  • 2李瑞燕,李晓辉.川崎病病因学研究进展[J].心血管病学进展,2010,31(4):616-620. 被引量:30
  • 3López-Cuenca A,Marín F,Roldán V. Genetic polymorphisms and atrial fibrillation:insights into the prothrombotic state and thromboembolic risk[J].Annals of Medicine,2010,(08):562-575.
  • 4De Meyer SF,Schwarz T,Schatzberg D. Platelet glycoprotein Ibα is an important mediator of ischemic stroke in mice[J].Exp Transl Stroke Med,2011,(13):9.
  • 5Mo X,Nguyen NX,Mu FT. Transmembrane and trans-subunit regulation of ectodomain shedding of platelet glycoprotein Ibalpha[J].Journal of Biological Chemistry,2010,(42):32096-32104.
  • 6胡亚美;江载芳.诸福棠实用儿科学[M]北京:人民卫生出版社,2002698-704.
  • 7吴丹,黄美蓉.川崎病并发冠状动脉损害的诊断及治疗进展[J].医学综述,2011,17(3):383-386. 被引量:10
  • 8Broos K,Trekels M,Jose RA. Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction[J].Journal of Biological Chemistry,2012,(12):9461-9472.
  • 9Santiago-Germán D,Leanos-Miranda A,García-Latorre E. Platelet glycoprotein ⅢA P1A2 polymorphism is associated with ST elevation acute myocardial infarction in young Mexican population[J].Journal of Thrombosis and Thrombolysis,2012,(04):389-396.
  • 10Murata M,Matsubara Y,Kawano K. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation[J].Circulation,1997,(10):3281-3286.

二级参考文献77

  • 1黄国英,马晓静,黄敏,陈树宝,黄美蓉,邱定忠,过仲珍,蒋瑾瑾,周晓迅,于清,桂永浩,宁寿葆,张拓红,杜忠东,Hiroshi Yanagawa,Tomisaku Kawasaki.上海地区1998-2002年川崎病流行病学特征[J].中国循证儿科杂志,2006,1(1):8-13. 被引量:62
  • 2刘颖.川崎病患儿PS、ES、VEGF血清含量变化的研究[J].中国妇幼保健,2006,21(18):2538-2539. 被引量:9
  • 3Cheung YF,Huang GY,Chen SB,et al.Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and arterial sequelae[J].Pediatrics,2008,122(3):e608-614.
  • 4Kariyazono H,Ohno T,Khajoee V,et al.Association of vascular endothelial growth factor(VEGF)and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease[J].Pediatr Res,2004,56(6):953-959.
  • 5Nishimura S,Zaitsu M,Hara M,et al.A polymorphism in the promoter of the CD14 gene (CD14/-159)is associated with the development of coronary artery lesions in patients with Kawasaki disease[J].J Pediatr,2003,143(3):357-362.
  • 6Ikeda K,Ihara K,Yamaquchi K,et al.Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease[J].Pediatr Res,2008,23(2):182-185.
  • 7Minami T,Suzuki H,Takeuchi T,et al.A polymorphism in plasma platelet activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease[J].J Pediatr,2005,147(1):78-83.
  • 8Kim JJ,Hong SJ,Hong YM,et al.Genetic variants in the HLA-G region are associated with Kawasaki disease[J].Human Immunol,2008,69(10):867-871.
  • 9Pinna GS,Kafetzis DA,Tselkas OI,et al.Kawasaki disease:an overview[J].Curr Opin Infect Dis,2008,21(3):263-270.
  • 10Nakamura Y,Yashiiro M,Uehara R,et al.Increasing incidence of Kawasaki disease in Japan:nationwide survey[J].Pediatr Intern,2008,50(3):287-290.

共引文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部